Eton Pharmaceuticals, Inc.
ETON
Jodie situation report
Eton Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 11 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- ETON's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ETON's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ETON
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TEVATeva Pharmaceutical Industries LimitedsupplierMar 19, 2026 ▾
“In December 2024, the Company acquired GALZIN® (zinc acetate) from Teva Pharmaceuticals USA, Inc and assumed the commercialization of the product in the U.S.”
Depended on by
HROWHarrow, Inc.investeeNov 10, 2025 ▾
“Investment Loss from Eton During the three and nine months ended September 30, 2024, we recorded a loss of $0 and $3,171,000, respectively, related to the change in fair market value of common stock of Eton Pharmaceuticals, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ETON is currently a Leader in the organic co-movement group Healthcare Real Estate. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ETON; it is not active in the latest market snapshot.